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Abstract 
Background: Concurrent malaria and arbovirus infections are common and represent an important public health 
concern in regions where both diseases are endemic. The present study investigates the genetic diversity and com‑
plexity of Plasmodium falciparum infection in concurrent malaria‑arbovirus infections in Kedougou region, southeast‑
ern Senegal.
Methods: Parasite DNA was extracted from 60 to 27 sera samples collected from P. falciparum isolates of malaria and 
concurrent malaria‑arbovirus infected patients, respectively, and followed by PCR‑genotyping targeting the msp‑1 
(block2) and msp‑2 (block3) allelic families.
Results: The mean number of genotype per allelic family was comparable between the two groups. K1 was the 
predominant msp‑1 allelic type both in malaria (94.91 %) and arbovirus‑malaria (92.59 %) groups, whereas IC/3D7 
was the most prevalent msp‑2 allelic type in malaria (94.91 %) and arbovirus‑malaria (96.29 %) groups. Frequencies of 
msp‑1 and msp‑2 allelic types were statistically comparable between the two groups (Fisher exact test, P > 0.05) and 
were not associated with age. FC27 was strikingly the least prevalent in both groups and was absent in children under 
5 years of age. The proportions of P. falciparum isolates from malaria‑infected patients carrying the three msp‑1 allelic 
types (67.44 %) or the two msp‑2 allelic types (76.47 %) were significantly higher than those from arbovirus‑malaria 
co‑infected patients (Exact binomial test, P < 0.05). The multiplicities of infection (MOI) were low and comparable for 
msp‑1 (1.19 vs 1.22) and msp‑2 (1.11 vs 1.10), respectively between malaria and arbovirus‑malaria groups.
Conclusion: The study showed no difference in the genetic diversity between P. falciparum isolates from malaria and 
concurrent malaria‑arbovirus infected patients in Kedougou. The MOI was low despite intense malaria transmission in 
Kedougou. The overall results suggest a limited or no influence of arbovirus infections on P. falciparum diversity and 
complexity of malaria infection.
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Background
Malaria and arboviruses infections are common arthro-
pod-borne diseases in Africa and represent major public 
health problems, as both diseases have been indepen-
dently associated with significant morbidity and mortal-
ity [1, 2]. Concurrent malaria and arbovirus infections 
have been reported previously [3–5], but its burden, clin-
ical significance and public health impact remain elusive 
mostly due to the lack of diagnostics capacities for arbo-
viruses or the low sensitivity of malaria detection meth-
ods in countries where the two diseases are prevalent or 
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endemic [6–8]. A recent study reported frequent concur-
rent malaria parasite and arbovirus infections in acute 
febrile patients in Kedougou region (southeastern Sen-
egal) strongly associated with high fever (≥40  °C) com-
pared to malaria or arbovirus infection alone [9]. To date, 
relatively little is known with regards to the nature of 
precise interactions during concurrent malaria-arbovirus 
infections.
While the interactions of malaria with parasitic 
infections, such as helminths, or viral infections, such 
as HIV, have been extensively documented [10–12], 
relatively little is known with regards to malaria and 
arboviruses co-infections. For example, investigations 
of the nature of interactions between helminths and 
malaria led to contradictory results probably as the 
result of the complex nature of the immune response 
to malaria parasites, due to the antigenic diversity of 
Plasmodium stages, or the altered immune responses 
resulting from co-infections [13]. The latter altered 
immune responses have been associated with greater 
complexity of malaria infection and parasite genetic 
diversity, one of the limitations to the development of 
an effective vaccine against Plasmodium falciparum 
malaria [14, 15].
Since malaria and arboviral infections often coincide 
geographically in the same tropical regions, the question 
arises whether arboviral infections modulate the immune 
responses towards the malaria parasite and affect the 
course and the complexity of malaria infection. A pro-
found effect of arboviral infections on the immune sys-
tem might be expected to influence the immune response 
against malaria parasites, thus affecting the course of 
infection and contributing to the complexity of the 
malaria disease.
In malaria endemic regions, studies have demon-
strated that individuals can be simultaneously infected 
with multiple P. falciparum populations that are geneti-
cally distinct [16–19]. Such multiple infections are 
believed to play an important role in the development of 
strain-specific immunity and have been associated with 
increased risk of treatment failure [20–22]. The P. falcipa-
rum merozoite surface proteins (msp-1 and msp-2) have 
been widely used as markers to investigate the genetic 
diversity, multiplicity of infection, level of malaria trans-
mission, as well as relationship with immunity against 
malaria [23, 24].
As no study has been reported so far on the extent of 
the genetic diversity of P. falciparum isolates in concur-
rent malarial infection, this study investigated the genetic 
diversity of P. falciparum isolates from patients infected 
only with malaria parasites or co-infected with arbovi-




A total of 101 sera from patients that have visited health-
care facilities in the Kedougou region between July 2009 
and July 2013 were withdrawn from a collection estab-
lished as part of a project investigating dengue infections 
in Kedougou region and investigated in this study. Due 
to the similar clinical presentation between malaria and 
arboviral infection, malaria diagnostic was systematically 
conducted to differentiate arboviral infection to malaria. 
During inclusion, all patients presented with acute 
febrile illness (AFI) which was defined as “any patient 
older than 1  year with a fever (temperature >38  °C) 
lasting for less than 2  weeks, exhibiting two or more of 
the following symptoms: headache, myalgia, eye pain, 
arthralgia, cough, nausea/vomiting, diarrhoea, jaundice, 
bleeding and neurological signs”. Clinical manifestations 
and socio-demographic data were recorded on a stand-
ardized interview form.
Study objectives, benefits and risks were explained in 
French or local languages to all participants before inclu-
sion. Written informed consent was obtained from adults 
and parents or legal guardians of children. The study 
was examined and approved by the Senegalese National 
Health Research Ethical Committee.
Malaria and arbovirus laboratory diagnostics
All 101 sera were systematically tested for P. falciparum 
malaria and arboviruses infections. Malaria diagnostic 
was initially performed by microscopic examination of 
Giemsa-stained thick blood smears and/or a rapid diag-
nostic test (Malaria Antigen P.f, Standard diagnostics, 
INC. Ingbert, Germany) while IgM antibodies capture 
ELISA, real-time RT-PCR and virus isolation methods 
[25, 26] were used for detection of arboviruses.
Consequently, “arbovirus confirmed case” was defined 
as “any AFI tested positive for any method used for detec-
tion of IgM and/or genome of ZIKV, DENV, CHIKV, 
RVFV, CCHFV, WNV or YFV” while malaria “confirmed 
case” was considered for “any AFI tested positive by RDT 
and/or microscopy”. Concurrent infection was defined 
as “any AFI confirmed for any arbovirus infection and 
malaria”.
Molecular detection of Plasmodium falciparum
The detection of Plasmodium DNA in frozen serum sam-
ples has been reported earlier [27, 28]. Genomic DNA 
isolation of Plasmodium parasites was performed using 
QIAamp DNA Blood Mini Kit (Qiagen, Hilden, Ger-
many) according to manufacturer’s instructions with 
minor modifications. Hundred microlitres (100  µl) of 
serum samples were used for extraction instead of 200 µl 
and final elution of isolated DNA was performed in 50 µl 
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volume. DNA was stored at −20  °C until further analy-
sis. DNA extracted from 100  µl of heparinized whole 
blood samples from known smear-positive P. falciparum 
malaria patient was used as positive control.
Qualitative detection of P. falciparum parasite DNA 
was based on nested PCR amplification with primers tar-
geting the Plasmodium spp 18S small subunit ribosomal 
RNA gene as described by Snounou and others [29]. The 
primary PCR amplification was performed with Plasmo-
dium genus specific rPLU5 and rPLU6 primers pairs [30, 
31] and 2 µl of extracted DNA in a total volume of 25 µl 
using the GoTaq Green Master Mix protocol (Catalog no 
M7113, Promega). The nested reaction was performed 
for the specific detection of P. falciparum using previ-
ously described primers pairs rFAL1 and rFAL2 [29, 31] 
in a total volume of 25 µl containing 1 µl of the primary 
PCR product. Nested PCR results were scored as cat-
egorical variables (presence vs absence of amplification). 
PCR cycling reactions and amplification conditions were 
as described by Snounou and Singh [29].
Molecular genotyping of Plasmodium falciparum isolates
Plasmodium falciparum isolates from malaria and con-
current arbovirus-malaria infected patients were ana-
lysed by amplification of the two highly polymorphic 
regions of msp-1 (block2) and msp-2 (block 3) using 
nested PCR as described previously [32, 33]. Sequences 
of primers sets used for detecting the three families of 
msp-1 (K1, MAD20 and RO33) and two families of msp-
2 (FC27 and 3D7) are reported elsewhere [33–35]. An 
initial amplification of the outer regions of the two genes 
was followed by a nested-PCR with allelic family specific 
primers pairs. In the first round reaction, 2 µl of genomic 
DNA was added as a template while in the nested reac-
tion, 1 µl of the outer PCR product was used as template. 
Amplification products were separated by electrophore-
sis on 1.5 % agarose gel, and the fragments were visual-
ized under UV light with ethidium bromide. The sizes 
were determined using a molecular weight marker.
The frequency of each msp family was calculated as the 
percentage of samples containing at least one allele from 
that family. The mean multiplicity of infection (MOI) or 
number of genotypes per infection [24, 36] was calcu-
lated by dividing the total number of fragments detected 
in msp-1 or msp-2 by the number of samples positive for 
the same marker.
Statistical analysis
Data were analysed using R statistical software version 
3.1.1 (2014-07-10) [37]. We performed Kruskal–Wallis 
and Fisher’s exact tests to compare distribution of quanti-
tative and qualitative variables respectively between sub-
groups. When pair-wise comparisons were performed 
between more than two groups, P values corrected for 
multiple testing by the Bonferroni method were per-
formed. Statistical significance was considered when P 
values were less than or equal to 0.05.
Results
Characteristics of the study population
Sera from 101 patients aged between one and 59  years 
were retrieved from the sera bank and investigated in 
this study for P. falciparum and arboviruses infections. 
Among them, 32 were uniquely positive for P. falciparum 
based on RDT and/or microscopy examination (Fig.  1, 
branch A), 18 were concurrently positive for P. falcipa-
rum and arboviral infections (Fig. 1, branch B), 13 were 
uniquely infected by arboviruses (Fig. 1, branch C), while 
38 were negative for both arboviral and malaria infec-
tions (Fig. 1, branch D). Due to the limited sensitivity of 
RDT and microscopy to detect low-density parasitaemia, 
nested PCR was performed on the 51 malaria negative 
samples (C +  D) for further detection of malaria para-
sites. This revealed 37 additional P. falciparum positive 
samples, of which 9 were co-infected with an arbovi-
rus (Fig.  1, branch C2) while 28 were uniquely infected 
by malaria parasite (Fig.  1, branch D2). This raises the 
number of unique P. falciparum malaria and concurrent 
malaria-arboviruses infections to 60 (A  +  D2) and 27 
(B + C2), respectively (Fig. 1).
The sex ratios M/F were 1.40 (35/25) and 1.07 (14/13) 
for the malaria and arbovirus-malaria groups respec-
tively (Table  1). The mean age was 20.13 (1–60) and 
22.07 (2–50) years respectively for the malaria and arbo-
virus-malaria groups (Table  1). The malaria and arbo-
virus-malaria groups were comparable in term of age 
Fig. 1 Flow chart describing the selection of the malaria and malaria‑
arboviruses infected samples
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(Kruskal–Wallis P value = 0.59) and sex (Fisher’s exact P 
value = 0.64).
Genetic diversity of Plasmodium falciparum isolates
Parasites DNA from all 60 P. falciparum-infected and 
27 concurrent P. falciparum-arbovirus co-infected sam-
ples were successfully genotyped. All three families of 
msp-1 (K1, MAD20 and RO33) and two families of msp-
2 (IC/3D7 and FC27) were detected in P. falciparum 
isolates from both malaria and arbovirus-malaria co-
infected patients.
In the malaria group, 40.46  % (70/173) of the overall 
detected msp-1 genotypes belonged to MAD20 allelic 
family while K1 and RO33 allelic families represented 
respectively 32.94 % (57/173) and 26.58 % (46/173) of the 
total msp-1 genotypes (Table 2). With respect to arbovi-
rus-malaria co-infected group, the MAD20 family was 
also the predominant msp-1 genotype and represented 
40  % (34/85) of the overall detected msp-1 genotypes 
whereas K1 and RO33 allelic families represented 30.58 % 
(26/85) and 29.41 % (25/85), respectively (Table 2).
The IC/3D7 allelic type was the predominant msp-2 
genotype in both malaria and arbovirus-malaria groups 
with respectively 77.92  % (60/77) and 88.23  % (30/34) 
of the total detected msp-2 genotypes. FC27 allelic type 
represented only 22.07  % (17/77) and 11.76  % (4/34) 
of msp-2 genotypes in malaria and arbovirus-malaria 
groups, respectively (Table 2).
For a given msp-1 or msp-2 allelic family, the total 
number of genotypes was higher in the malaria group 
than in the arbovirus-malaria group. However, the 
mean number of genotype per allelic family was compa-
rable between the two groups (0.96 vs 0.96 for K1, 1.18 
vs 1.21 for MAD20, 0.77 vs 0.89 for RO33, 1.01 vs 1.07 
for IC/3D7 and 0.28 vs 0.14 for FC27). This suggests 
that the elevated number of genotypes observed in the 
malaria group could be due to the higher number of sam-
ples from malaria-infected patients rather than a lower 
genetic diversity of P. falciparum isolates from concur-
rent arbovirus-malaria infected patients.
Frequency of msp‑1 and msp‑2 allelic types in the study 
groups
The frequency of K1, MAD20 and RO33 allelic families 
of msp-1 and IC/3D7 and FC27 allelic families of msp-2 
were compared between malaria and arbovirus-malaria 
groups. In both groups, K1 and IC/3D7 families were 
respectively the predominant msp-1 and msp-2 allelic 
types (Fig.  2a). The frequencies of msp-1 specific allelic 
types were statistically comparable between the malaria 
and arbovirus-malaria groups and were respectively 95 
vs 92.59 % for K1 (P value = 0.64), 78.33 vs 81.48 % for 
MAD20 (P value = 0.99) and 73.33 vs 74.07 % for RO33 
(P value = 0.99) (Fig. 2a).
Similar to msp-1 allelic types, the frequencies of msp-
2 specific allelic types were also statistically compara-
ble between P. falciparum isolates from malaria and 
arbovirus-malaria patients and were 93.33 vs 96.29 for 
IC/3D7 (P value =  0.99) and 23.33 vs 14.81 % for FC27 
(P value =  0.57) (Fig.  2a). FC27 was strikingly the least 
prevalent allelic family in both groups (Fig. 2a).
The proportion of P. falciparum isolates carrying simul-
taneously the three msp-1 allelic types and the two msp-2 
allelic types were also compared between the two groups 
and reported in Fig. 2b. The proportion of P. falciparum 
isolates from malaria-infected patients carrying the three 
msp-1 allelic types (67.44  %) was significantly higher 
than that from arbovirus-malaria co-infected patients 
(32.56 %) (Exact binomial test, P = 0.013). A similar dis-
tribution was observed between P. falciparum isolates 
carrying the two msp-2 allelic types from simple malaria 






OR (95 % CI) P value
N (%) N (%)
Age (year)
 Mean (SD) 20.13 (14.2) 22.07 (15.4) 0.59
 (Range) (1–60) (2–50)
Sex
 Male 35 (58.3) 14 (51.8) –
 Female 25 (41.7) 13 (48.2) 1.29 (0.47–3.57) 0.64
 Ratio M/F 1.40 1.07
Age groups (years)
 ≤5 8 (14.94) 5 (18.51) –
 (5–15) 17 (26.43) 6 (22.22) 0.57 (0.11–3.15) 0.68
 >15 35 (58.62) 16 (59.25) 0.74 (0.18–3.33) 0.86
Table 2 Total and mean number of genotype per allelic family
Total (mean) msp‑1 msp‑2
K1 MAD20 RO33 Total IC/3D7 FC27 Total
Malaria 57 (0.96) 70 (1.18) 46 (0.77) 173 60 (1.01) 17 (0.28) 77
Arbovirus‑malaria 26 (0.96) 34 (1.21) 25 (0.89) 85 30 (1.07) 4 (0.14) 34
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(76.47  %) and arbovirus-malaria (23.53  %) cases (Exact 
binomial test, P = 0.032) (Fig. 2b).
Distribution of msp‑1 and msp‑2 allelic families according 
to age groups
The frequency of specific msp-1 and msp-2 allelic fam-
ilies were categorized within three age groups: ≤5, 
(5–15) and >15  years (Table 1). For a given msp-1 and 
msp-2 allelic family, there was an age-dependant distri-
bution of the frequency of allelic types from P. falcipa-
rum malaria-infected isolates with patients in the oldest 
age group (>15  years) showing the highest frequency 
(Fig.  3a). Frequencies of the three msp-1 allelic types 
(K1, MAD20 and RO33) as well as the two msp-2 allelic 
types (IC/3D7 and FC27) were comparable within age 
groups.
By contrast, the distribution of msp-2 allelic types of P. 
falciparum isolates from arbovirus-malaria co-infected 
patients according to age groups showed a slightly differ-
ent pattern (Fig.  2b) characterized by a lower frequency 
of MAD20, RO33 and IC/3D7 allelic famiilies in the 
(5–15  years) age group and an absence of FC27 allelic 
family in children below 5  years old (Fig.  3b). However, 
no significant difference was found for K1 (P  =  0.89), 
MAD20 (P = 0.54), RO33 (P = 0.88), IC/3D7 (P = 0.89) 
and FC27 (P  =  1.00) when comparing age-distribution 
of a given allelic family between malaria and arbovirus-
malaria groups using Fisher exact test.
Multiplicity of Plasmodium falciparum infection
The mean multiplicity of P. falciparum infection (MOI) 
was found to be 1.19 and 1.11 respectively for msp-1 
Fig. 2 Frequency of individual (a) or combined (b) msp-1 and msp-2 allelic families of Plasmodium falciparum isolates from malaria and malaria‑
arbovirus infected patients
Fig. 3 Distribution of msp‑1 and msp‑2 allelic families of Plasmodium falciparum isolates from malaria (a) and concurrent malaria and arbovirus (b) 
infected patients according to age groups
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and msp-2 in the malaria group (Fig. 4a). In the arbovi-
rus-malaria group, the mean MOI was 1.22 and 1.1 for 
msp-1 and msp-2, respectively (Fig. 4a). The distribution 
of msp-1 and msp-2 mulitiplicity of infection accord-
ing to the three age groups showed no association with 
age (Fig. 4b). The difference in MOI for msp-1 and msp-
2 between malaria and arbovirus-malaria groups as 
well between age groups was not statistically significant 
(P > 0.05).
Discussion
In resources-limited settings, given the limited num-
ber of laboratories diagnosing arboviral infections along 
with malaria infections, reports on malaria and arbovirus 
co-infections are scarce and their prevalence underesti-
mated [3–5, 9, 38]. PCR has been shown to be more relia-
ble in detecting malaria parasite [6, 7, 39] as confirmed in 
the current study showing that not only PCR could detect 
malaria parasite in all microscopy-positive samples but 
also in samples found negative by microscopy [7, 40]. The 
study showed that microscopy-based diagnostic of P. fal-
ciparum highly underestimated malaria parasite carriage. 
Importantly, Plasmodium DNA was detected from fro-
zen serum samples similar to previous reports [27, 28], 
providing the potential for retrospective diagnostic of 
active malaria infections in patients cohorts to determine 
potential interactions of malaria with others diseases.
In this study, the genetic diversity exhibited by P. fal-
ciparum isolates from malaria-infected patients and 
concurrent arboviruses-malaria co-infected patients 
was investigated in Kedougou region with an ultimate 
goal of determining whether co-infection with an arbo-
virus contributed to the overall genetic diversity of 
P. falciparum isolates and complexity of malaria infec-
tions. Both malaria and arbovirus-malaria groups were 
comparable in term of age, sex and percentage of patients 
within defined age groups.
The comparable mean number of genotype for each 
locus between malaria and arbovirus-malaria groups sug-
gested that the elevated number of genotypes observed in 
the malaria group could be related to the higher number 
of samples rather than an extended genetic diversity of 
P. falciparum isolates from malaria-infected patients. In 
this study, the frequency of all msp-1 allelic families (K1, 
MAD20 and RO33) and IC/3D7 allelic family of msp-2 
were high (>70 %) and comparable between the two study 
groups. The current parasite profile with the predomi-
nance of K1 and IC/3D7 allelic families was also reported 
in others studies [41–43]. The highly significant differ-
ences observed between the proportions of P. falcipa-
rum isolates carrying either the three msp-1 allelic types 
or the two msp-2 allelic types from malaria-infected 
patients compared to arbovirus-malaria co-infected 
patients, are probably uniquely due to elevated number 
of sample concerning simple infection compared to co-
infection. The distribution of msp-1 and msp-2 families 
according to age groups was similar between malaria and 
arbovirus-malaria groups and no significant difference 
was found when comparing distribution of a given allelic 
family between the two groups despite the absence of 
FC27 family in younger children (<5 years).
The MOI reported in this study was not influenced 
by age similar to reports from others studies [44]. This 
contrasts with studies that have shown a greater MOI in 
adults [45, 46] as well as findings of decreased MOI with 
age [47, 48]. The lack of association between MOI and 
Fig. 4 Distribution of msp‑1 and msp‑2 multiplicity of infection in malaria and arbovirus‑malaria groups (a) and their distribution according to age 
groups (b)
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age could suggest that the MOI is not directly related to 
the period of acquisition of immunity. Thus, a study of 
the MOI and immunity against asexual stages of P. falci-
parum showed that samples with the highest MOI came 
from children with significantly lower antibody responses 
to specific antigens of the asexual parasite [43]. Malaria 
episodes with many clones would induce a diversity-
driven delayed acquired immunity with consequent lim-
ited ability to control malaria infection. The low allelic 
diversity together with the high frequency of the circu-
lating allelic families increases the chance of the re-infec-
tion with the same allele.
Although the sera investigated in this study spanned a 
5-year period and originated from different health facili-
ties, possibly affecting the MOI as previously reported 
[49], the spatial and temporal dependencies of the differ-
ent genotypes were not analyzed in the present study. The 
frequency and distribution of msp-1 and msp-2 allelic 
families with respect to sampling period and health facili-
ties/villages of origin are being investigated in a more 
extensive study using 160 P. falciparum isolates from 
Kedougou (Niang M, personal communication).
Conclusion
This study provides the first information on the genetic 
diversity of P. falciparum isolates and complexity of infec-
tion in concurrent arbovirus-malaria infections. The study 
revealed no influence of arboviral infection on the genetic 
diversity of P. falciparum isolates as well as complexity of 
P. falciparum malaria infections in Kedougou. The study 
did not find any msp-1 and/or msp-2 allelic type fre-
quency, MOI or distribution of a given allelic type or MOI 
with age groups that would suggest a role of arboviruses 
infections on the genetic diversity of P. falciparum isolates 
and complexity of malaria infection in Kedougou. Other 
studies that examine P. falciparum population struc-
ture and, taking into account the nature of anti-malarial 
immune responses are needed to better document the 
influence of arboviruses infections on P. falciparum 
genetic diversity and complexity of malaria infection.
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